<?xml version="1.0" encoding="UTF-8"?>
<p>Adverse events occurring during the study follow up period will be analysed and compared between groups. This will be a descriptive analysis and will include all AEs up to 28 days post-vaccination, and SAEs that occurred any time during study follow-up.</p>
